These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8225827)

  • 1. Neoadjuvant (induction) chemotherapy in advanced bladder carcinoma.
    Türkeri L; Ilker Y; Simşek F; Akdaş A
    Int Urol Nephrol; 1993; 25(3):259-63. PubMed ID: 8225827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of high-stage bladder cancer: case for adjunctive chemotherapy.
    Walther PJ
    Semin Urol; 1993 May; 11(2):69-73. PubMed ID: 8362122
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neoadjuvant chemotherapy in muscle-invasive bladder cancer].
    Miyanaga N; Akaza H
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1745-9. PubMed ID: 18030008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neo-adjuvant intra-arterial chemotherapy in locally advanced bladder cancer.
    Chechile G; Montie J; Pontes JE; Bukowski RM
    Prog Clin Biol Res; 1990; 353():153-61. PubMed ID: 2217413
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
    Walther PJ
    Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828
    [No Abstract]   [Full Text] [Related]  

  • 7. [Place of chemotherapy in the treatment of invasive bladder tumors].
    Pariente JL; Theodore C; Davin JL; Rischmann P; Chopin D
    Prog Urol; 1999 Apr; 9(2):219-24. PubMed ID: 10370944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant treatment for invasive bladder cancer: is it worthwhile?
    Hall RR
    Acta Urol Belg; 1996 May; 64(2):39-42. PubMed ID: 8701809
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant chemotherapy for non-organ confined bladder transitional cell carcinoma.
    Abi-Aad AS
    Acta Urol Belg; 1996 May; 64(2):35-7. PubMed ID: 8701808
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
    Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
    Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Infiltrating tumors of the bladder. Local response to systemic platinum-based chemotherapy].
    Boccon-Gibod L; Adjiman S; Beuzeboc P; Steg A
    Ann Urol (Paris); 1989; 23(4):285-8. PubMed ID: 2686541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
    Birtle AJ; Huddart RA
    BJU Int; 2006 Jun; 97(6):1348; author reply 1348-50. PubMed ID: 16686740
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neoadjuvant chemotherapy for invasive bladder cancer].
    Kageyama Y; Kihara K
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1838-44. PubMed ID: 11729476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of systemic treatment of bladder cancer and results with M-VAC therapy.
    Yagoda A
    Prog Clin Biol Res; 1990; 350():87-99. PubMed ID: 2201047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristic and effective usage of adriamycin].
    Horiuchi K; Akimoto M
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1916-9. PubMed ID: 8978797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer.
    Nieuwenhuijzen JA; Bex A; Meinhardt W; Kerst JM; Schornagel JH; VAN Tinteren H; Horenblas S
    J Urol; 2005 Jul; 174(1):80-5. PubMed ID: 15947583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible alternative treatment for advanced transitional cell carcinoma of the urothelium (N+ and/or M+) in 1988.
    Perrin P; Mouriquand P; Monsallier M; Devonec M
    Prog Clin Biol Res; 1989; 303():617-9. PubMed ID: 2780666
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors.
    Angulo JC; Sanchez-Chapado M; Lopez JI; Flores N
    J Urol; 1996 Jun; 155(6):1897-902. PubMed ID: 8618282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conservative treatment of infiltrating cancer of the bladder: neoadjuvant chemotherapy and radiotherapy].
    Prié L; Gaston R; Ferrière JM; Richaud P; Bui BN; Guillou ML
    Cancer Radiother; 1998 Apr; 2 Suppl 1():62s-66s. PubMed ID: 9749081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer.
    Sternberg CN; Parmar MK
    J Clin Oncol; 2001 Sep; 19(18 Suppl):21S-26S. PubMed ID: 11560967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.